Response: Re: Adjuvant treatment of high-risk, radically resected rastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial [5]

Journal of the National Cancer Institute

Volumn 99, Issue 17, 2007, Pages 1346-1347

  Cascinu, Stefano ^a   Scartozzi, Mario ^a   Barone, Carlo ^b   Labianca, Roberto ^c   Santoro, Armando ^d   Carnaghi, Carlo ^d   Beretta, Giordano D ^c   Catalano, Vincenzo ^e   Barni, Sandro ^f   Frontini, Luciano ^g  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^c OSPEDALI RIUNITI   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e SAN SALVATORE HOSPITAL   (Italy)

^f TREVIGLIO HOSPITAL   (Italy)

^g GISCAD   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; IRINOTECAN;

CANCER ADJUVANT THERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG TOLERABILITY; HUMAN; LETTER; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL TIME;

EID: 34548583393     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djm094     Document Type: Letter

References (6)

1. Cascinu S, Labianca R, Barone C, Santoro C, Carnaghi C, Cassano A, et al. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epi-doxorubicin in a randomized controlled trial. J Natl Cancer Inst 2007;99:601-7.
2. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastro-esophageal cancer. N Engl J Med 2006;355:11-20.
3. Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, et al. Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: A report of the V325 Study Group. J Clin Oncol 2006;24:4991-7.
4. Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: A meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 2000;11:837-43.
5. Bajetta E, Buzzoni R, Mariani L, Beretta E, Bozzetti F, Bordogna G, et al. Adjuvant chemotherapy in gastric cancer: 5-year results of a randomised study by the Italian trials in Medical Oncology (ITMO) Group. Ann Oncol 2002;13:299-307.
6. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmerman GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001;345:725-30.